Compare
5 stocks, side by sideRelative performance · rebased to 100
RCUSRLAYNAMSCRNXDNLI
| RCUSArcus Biosciences, Inc. | RLAYRelay Therapeutics, Inc. | NAMSNewAmsterdam Pharma Company N.V. | CRNXCrinetics Pharmaceuticals, Inc. | DNLIDenali Therapeutics Inc. | |
|---|---|---|---|---|---|
| Smart Score | 8/10 | 9/10 | 3/10 | 4/10 | 9/10 |
| Price | $30.25 | $17.83 | $31.73 | $34.99 | $24.73 |
| 1 month | +25% | +26% | -12% | -4.9% | +28% |
| 1 year | +246% | +439% | +72% | +13% | +72% |
| 5 year | +27% | -49% | +225% | +81% | -67% |
| P/E (TTM) | -10.3 | -14.2 | -17.4 | -7.4 | -7.7 |
| P/E vs sector | - | - | - | - | - |
| Market cap | $3.8B | $3.9B | $3.7B | $3.7B | $3.9B |
| Sector | Healthcare | Healthcare | Healthcare | Healthcare | Healthcare |
Risk / Return · past yearAnnualized return vs volatility, up-and-left is more reward for less risk.
Correlation · do they move together?Pairwise daily-return correlation over the past year, high = one bet, low = diversifying.